Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 166

1.

Expression of matrix metalloproteinase-13 and Ki-67 in nonmelanoma skin cancer in xeroderma pigmentosum and non-xeroderma pigmentosum.

El-Hawary AK, Yassin E, Khater A, Abdelgaber S.

Am J Dermatopathol. 2013 Feb;35(1):45-9. doi: 10.1097/DAD.0b013e31825aa334.

PMID:
22722466
2.

Immunohistochemical prognostic criteria in xeroderma pigmentosum.

Karakok M, Turkmen A, Bekerecioglu M, Koçer NE.

Int J Dermatol. 2010 Nov;49(11):1266-71.

PMID:
21038547
3.

Xeroderma pigmentosum skin: an immune privilege site for tumor development.

Abid K, El Mezni F, Kamoun MR, Fazaa B, Zermani R, Hadouchi C, Hamzaoui K.

J Cutan Pathol. 2010 Apr;37(4):452-9. doi: 10.1111/j.1600-0560.2009.01401.x. Epub 2009 Aug 27.

PMID:
19719835
4.

p53 protein expression and cell proliferation in non-neoplastic and neoplastic proliferative skin diseases.

Batinac T, Zamolo G, Jonjić N, Gruber F, Petrovecki M.

Tumori. 2004 Jan-Feb;90(1):120-7.

PMID:
15143984
5.

Immunohistochemical expression of sperm-associated antigen 9 in nonmelanoma skin cancer.

Seleit I, Bakry OA, Samaka RM, Malak MA.

Am J Dermatopathol. 2015 Jan;37(1):38-45. doi: 10.1097/DAD.0000000000000126.

PMID:
25033008
6.

[Expression and significance of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase in non-melanoma skin cancer].

Fu XR, Zhang C, Chen CY, Zhang L, Wang LX, Wang BH, Liu XY, Zhang MZ.

Zhonghua Zhong Liu Za Zhi. 2012 May;34(5):369-73. doi: 10. 3760/cma.j.issn.0253-3766.2012.05.011. Chinese.

PMID:
22883459
7.

Immunohistochemical analysis of TIMP-3 and MMP-9 in actinic keratosis, squamous cell carcinoma of the skin, and basal cell carcinoma.

Poswar FO, Fraga CA, Farias LC, Feltenberger JD, Cruz VP, Santos SH, Silveira CM, de Paula AM, Guimarães AL.

Pathol Res Pract. 2013 Nov;209(11):705-9. doi: 10.1016/j.prp.2013.08.002. Epub 2013 Aug 16.

PMID:
24011615
8.

Lamin expression in normal human skin, actinic keratosis, squamous cell carcinoma and basal cell carcinoma.

Tilli CM, Ramaekers FC, Broers JL, Hutchison CJ, Neumann HA.

Br J Dermatol. 2003 Jan;148(1):102-9.

PMID:
12534602
9.

Immunohistochemical expression of MCM2 in nonmelanoma epithelial skin cancers.

Abdou AG, Elwahed MG, Serag El-Dien MM, Eldien DS.

Am J Dermatopathol. 2014 Dec;36(12):959-64. doi: 10.1097/DAD.0000000000000114.

PMID:
24936676
10.

Xeroderma pigmentosum in Libya.

Khatri ML, Bemghazil M, Shafi M, Machina A.

Int J Dermatol. 1999 Jul;38(7):520-4.

PMID:
10440281
11.

Prevalence of human papillomavirus in skin tumors from repair deficient xeroderma pigmentosum patients.

Luron L, Avril MF, Sarasin A, Daya-Grosjean L.

Cancer Lett. 2007 Jun 8;250(2):213-9. Epub 2006 Nov 28.

PMID:
17126994
12.

Squamous cell carcinoma of the lower lid in a 19-month-old girl with xeroderma pigmentosum.

Hadi U, Tohmeh H, Maalouf R.

Eur Arch Otorhinolaryngol. 2000;257(2):77-9. Review.

PMID:
10784366
14.

Expression of basement membrane antigens and matrix metalloproteinases 2 and 9 in cutaneous basal and squamous cell carcinomas.

Dumas V, Kanitakis J, Charvat S, Euvrard S, Faure M, Claudy A.

Anticancer Res. 1999 Jul-Aug;19(4B):2929-38.

PMID:
10652575
15.

Comparative analysis of immunohistochemical markers with invasiveness and histologic differentiation in squamous cell carcinoma and basal cell carcinoma of the skin.

Son KD, Kim TJ, Lee YS, Park GS, Han KT, Lim JS, Kang CS.

J Surg Oncol. 2008 Jun 1;97(7):615-20. doi: 10.1002/jso.21006.

PMID:
18404670
16.

Multiple melanomas occurring in a patient with xeroderma pigmentosum.

Tullis GD, Lynde CW, McLean DI, Stewart WD.

J Am Acad Dermatol. 1984 Aug;11(2 Pt 2):364-7.

PMID:
6480943
17.

Altered distribution of 1-2B7B antigen in basal cell carcinoma, squamous cell carcinoma and Bowen's disease.

Zhang XM, Horiguchi Y, Ueda M, Yoshiki T, Imamura S.

J Dermatol Sci. 1992 Jan;3(1):46-55.

PMID:
1591227
18.

Diagnosing xeroderma pigmentosum group C by immunohistochemistry.

de Feraudy S, Boubakour-Azzouz I, Fraitag S, Berneburg M, Chan L, Chew K, Clericuzio CL, Cunningham B, Tope WD, Cleaver JE.

Am J Dermatopathol. 2010 Apr;32(2):109-17. doi: 10.1097/DAD.0b013e3181af0a5e.

PMID:
19915453
19.

Cancer protection in xeroderma pigmentosum variant (XP-V).

Somos S, Farkas B, Schneider I.

Anticancer Res. 1999 May-Jun;19(3B):2195-9.

PMID:
10472330
20.

Malignant melanoma in xeroderma pigmentosum: search for a precursor lesion.

Stern JB, Peck GL, Haupt HM, Hollingsworth HC, Beckerman T.

J Am Acad Dermatol. 1993 Apr;28(4):591-4.

PMID:
8463460

Supplemental Content

Support Center